M-C Lee

发表

Phosphorylation of paxillin confers cisplatin resistance in non-small cell lung cancer via activating ERK-mediated Bcl-2 expression

Y. Cheng, C-Y Chen, T. Wu, 2014, Oncogene.

FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction

Y. Cheng, C-Y Chen, T. Wu, 2017, Oncogene.

FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction

Y. Cheng, C-Y Chen, T. Wu, 2014, Oncogene.

DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer

Y. Cheng, C-Y Chen, H. Lee, 2014, Oncogene.

Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia

S-J Wu, B. Ko, M. Yao, 2014, Leukemia.

c-Myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT

Y. Cheng, C-Y Chen, H. Lee, 2014, Oncogene.

FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction

Y. Cheng, C-Y Chen, T. Wu, 2015, Oncogene.